Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV)


Standort der Organisation:
Lausanne, Schweiz

Publikationen in Kooperation mit FAU-Wissenschaftern

Go to first page Go to previous page 1 von 2 Go to next page Go to last page
Kolios, A.G.A., Hueber, A., Michetti, P., Mrowietz, U., Mustak-Blagusz, M., Sator, P.-G.,... Schiefke, I. (2019). ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study. Journal of the European Academy of Dermatology and Venereology, 33(1), 234-241.
Strnad, P., Buch, S., Hamesch, K., Fischer, J., Rosendahl, J., Schmelz, R.,... Trautwein, C. (2019). Heterozygous carriage of the alpha1-antitrypsin Pi∗Z variant increases the risk to develop liver cirrhosis. Gut, 68(6), 1099-1107.
Pavel, M.E., Dromain, C., Thanh, T.X.M., & Houchard, A. (2019). Safety and Efficacy of 14-Day Dosing Interval of Lanreotide Autogel/Depot (LAN) for Pts with Pancreatic or Midgut Neuroendocrine Tumours (NETs) Progressing on LAN Every 28 Days: Prospective, Open-label, International, Phase 2 CLARINET FORTE Study. In NEUROENDOCRINOLOGY (pp. 157-157). BASEL: KARGER.
Papuc, S.M., Abela, L., Steindl, K., Begemann, A., Simmons, T.L., Schmitt, B.,... Rauch, A. (2019). The role of recessive inheritance in early-onset epileptic encephalopathies: a combined whole-exome sequencing and copy number study. European journal of human genetics, 27(3), 408-421.
Dromain, C., Pavel, M.E., Ruszniewski, P., Langley, A., Massien, C., Baudin, E., & Caplin, M.E. (2019). Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors. BMC Cancer, 19(1).
Lamarca, A., Ronot, M., Moall, S., Crona, J., Opalinska, M., Lopez, C.,... Dromain, C. (2019). Tumour Growth Rate (TGR) in Neuroendocrine Tumours (NETs): Changes Following Systemic Treatment; the GREPONET-2 Study. In NEUROENDOCRINOLOGY (pp. 137-137). BASEL: KARGER.
Lamarca, A., Crona, J., Ronot, M., Opalinska, M., Lopez Lopez, C., Pezzutti, D.,... Dromain, C. (2019). Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients’ Outcome in Neuroendocrine Tumors (NET)—The GREPONET Study. Oncologist.
Dittmar, D., Uter, W., Bauer, A., Fortina, A.B., Bircher, A.J., Czarnecka-Operacz, M.,... Schuttelaar, M.L. (2018). European Surveillance System on Contact Allergies (ESSCA): polysensitization, 2009-2014. Contact Dermatitis, 78(6), 373-385.
Gabay, C., Fautrel, B., Fautrel, B., Rech, J., Spertini, F., Feist, E.,... Schiffrin, E.J. (2018). Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease. Annals of the Rheumatic Diseases, 77(6), 840-847.
Cazzaniga, S., Apfelbacher, C., Diepgen, T., Ofenloch, R.F., Weisshaar, E., Molin, S.,... Simon, D. (2018). Patterns of chronic hand eczema: a semantic map analysis of the CARPE registry data. British Journal of Dermatology, 178(1), 229-237.
Crona, J., Crona, J., Lamarca, A., Ronot, M., Opalinska, M., Lopez Lopez, C.,... Dromain, C. (2018). Pre-Treatment Tumor Growth Rate (TGR0) in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) Treated with Systemic Therapies: Subgroup Analysis of the GREPONET Study. (pp. 171-171).
Lee, M., Wlodarczak, A., Bennett, J., Torzewski, J., Haude, M., Vrolix, M.,... Verheye, S. (2018). Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First 400 Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry. (pp. B142-B143).
Lamarca, A., Crona, J., Ronot, M., Opalinska, M., Lopez Lopez, C., Pezzutti, D.,... Dromain, C. (2018). Value of Tumor Growth Rate (TGR) as an Early Predictor of Patients' Outcome in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs): The GREPONET Study. (pp. 178-178).
Messerli, F.H., Hofstetter, L., Agabiti-Rosei, E., Burnier, M., Elliott, W.J., Franklin, S.S.,... De Leeuw, P.W. (2017). Expertise: no longer a sine qua non for guideline authors? Journal of Hypertension, 35(8), 1564-1566.
Lewczuk, P., Lelental, N., Lachmann, I., Holzer, M., Flach, K., Brandner, S.,... Kornhuber, J. (2017). Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization. Journal of Alzheimers Disease, 55(1), 159-170.
Mahfoud, F., Schmieder, R., Azizi, M., Pathak, A., Sievert, H., Tsioufis, C.,... Wijns, W. (2017). Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future. European Heart Journal.
Rodionova, K., Fiedler, C., Günther, F., Grouzmann, E., Neuhuber, W., Fischer, M.,... Ditting, T. (2016). Complex reinnervation pattern after unilateral renal denervation in rats. American Journal of Physiology-Regulatory Integrative and Comparative Physiology, 310(9), R806-18.
Zanchetti, A., Liu, L., Mancia, G., Parati, G., Grassi, G., Stramba-Badiale, M.,... Ford, G. (2016). Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. Journal of Hypertension, 34(3), 393-6.
Girard, C., Rech, J., Brown, M., Allali, D., Roux-Lombard, P., Spertini, F.,... Gabay, C. (2016). Elevated serum levels of free interleukin-18 in adult-onset Still's disease. Rheumatology, 55(12), 2237-2247.

Zuletzt aktualisiert 2016-31-05 um 08:18